Alan M. Ezrin

A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation

Denis Roy, Brian H. Rowe, Ian G. Stiell et al. · Journal of the American College of Cardiology · 2004 · 223 citations

Thrombosis, Cardiovascular Disease, Pharmacology +10

The Mechanism of Atrial Antiarrhythmic Action of RSD1235

David Fedida, Peter Orth, JANET Y.C. CHEN et al. · Journal of Cardiovascular Electrophysiology · 2005 · 194 citations

In Vivo Collagen Turnover Following Experimental Balloon Angioplasty Injury and the Role of Matrix Metalloproteinases

Bradley H. Strauss, Ranga Robinson, Wayne Batchelor et al. · Circulation Research · 1996 · 161 citations

Characterization of renal ischemia-reperfusion injury in rats

Patricia D. Williams, Henry Lopez, Deborah Britt et al. · Journal of Pharmacological and Toxicological Methods · 1997 · 152 citations

Renal Ischemia-reperfusion Injury, Physiology, Vascular Biology +5

RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents

Peter Orth, John E. Hesketh, C MAK et al. · Cardiovascular Research · 2006 · 117 citations